Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2005
11/30/2005EP1600505A1 Escherichia coli phytase
11/30/2005EP1600460A1 Use of an active substance that binds to CD28 for producing a pharmaceutical composition for treatment of B-CLL
11/30/2005EP1600458A1 Novel gene relating to fibrotic conditions
11/30/2005EP1600457A1 Peptide derivatives having beta-secretase inhibitory activity
11/30/2005EP1600210A1 Charged microspheres
11/30/2005EP1600180A2 Antiproliferative drug and delivery device
11/30/2005EP1600165A1 Medicinal use of mip-3alpha inhibitor and method of screening brain/nerve cell protective agent
11/30/2005EP1600163A1 Use of the neurotoxic component of botulinum toxins for the treatment of spastic muscle
11/30/2005EP1600162A1 Shelf-stable formulation of glucagon-like peptide-1
11/30/2005EP1600160A1 Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opioid agonists
11/30/2005EP1600152A1 Use of LIF in cosmetics and dermatology
11/30/2005EP1600141A1 Collagenolytic active enzyme containing compositions, and their use in the dental field
11/30/2005EP1599715A2 Autologous or homologous coagulant produced from anticoagulated whole blood
11/30/2005EP1599603A1 Methods of diagnosis and prognosis of pancreatic cancer
11/30/2005EP1599600A2 DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 7A2 (PDE7a2)
11/30/2005EP1599595A2 N -acetylglucosaminyltransferase iii expression in lower eukaryotes
11/30/2005EP1599591A2 Methods of gene therapy for treating disorders of the ear by administering a vector encoding an atonal-associated factor
11/30/2005EP1599587A2 Compositions and methods for diagnosing and treating asthma or other allergic or inflammatory diseases
11/30/2005EP1599572A2 Compositions and methods for cancer immunotherapy
11/30/2005EP1599499A2 Periodic antimicrobial peptides
11/30/2005EP1599498A2 Compositions and methods for the treatment of systemic lupus erythematosis
11/30/2005EP1599496A2 Hepatitis c inhibitor peptide analogs
11/30/2005EP1599495A2 New dengue and west nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications
11/30/2005EP1599224A1 Inhibition of tace or amphiregulin for the modulation of egf receptor signal transactivation
11/30/2005EP1599222A1 Stabilized aqueous compositions comprising tissue factor pathway inhibitor (tfpi) or tissue factor pathway inhibitor variant
11/30/2005EP1599221A1 Treatment of sinusitis related chronic facial pain and headache with botulinum toxin
11/30/2005EP1599220A1 Selection of patients with increased responsiveness to botulinum toxin
11/30/2005EP1599219A1 Treatment of chronic chalazion and hordeolum with botulinum toxin
11/30/2005EP1599218A1 Clostridial neurotoxins for treating uterine disorders
11/30/2005EP1599217A2 Methods for inhibiting viral replication in vivo
11/30/2005EP1599216A2 Methods for preventing mitochondrial permeability transition
11/30/2005EP1599215A1 Use of tryptophan rich peptides
11/30/2005EP1599213A2 Cell membrane translocation of regulated snare inhibitors , compositions therefor, and methods for treatment of disease
11/30/2005EP1599212A2 Combination therapy for the treatment of immunoinflammatory disorders
11/30/2005EP1599188A2 POWDER FORMULATIONS OF RECOMBINANT STAPHYLOCOCCAL, ENTEROTOXIN B (<SB>R</SB>SEB) MADE BY ATMOSPHERIC SPRAY-FREEZE DRYING FOR IMPROVED VACCINATION
11/30/2005EP1599173A2 Synthetic single domain polypeptides mimicking apolipoprotein e and methods of use
11/30/2005EP1599171A2 Combination therapy for treating alphavirus infection and liver fibrosis
11/30/2005EP1599165A2 The use of gcc ligands
11/30/2005EP1485400A4 Human rnase iii and compositions and uses thereof
11/30/2005EP1430131B1 Muteins of human neutrophil gelatinase-associated lipocalin and related proteins
11/30/2005EP1335932B1 Isolation of lectins
11/30/2005EP1317483B1 Variants of allergenic proteins of the group 2 of dermatophagoides
11/30/2005EP1313488A4 Compositions and methods for improving cardiovascular function
11/30/2005EP1301605B1 Nk cells activating receptors and their therapeutic and diagnostic uses
11/30/2005EP1289537B1 Method of treating chronic ulcers
11/30/2005EP1282439B1 PHARMACEUTICAL COMPOSITION COMPRISING A FACTOR VIIa AND A TFPI INHIBITOR
11/30/2005EP1252179B1 High purity lipopeptides, lipopeptide micelles, processes for preparing same and pharmaceutical compositions containing them
11/30/2005EP1227794B1 Method for encapsulating proteins or peptides in liposomes
11/30/2005EP1223985B1 Dialysis solution including polyglycol osmotic agent
11/30/2005EP1192181B1 Modulation of angiogenesis by using the anti-angiogenic angiotensin-7 and polynucleotides encoding therefor for the treatment of tumor
11/30/2005EP1185306B1 Use of viral vectors and charged molecules for gene therapy
11/30/2005EP1178793B1 Stable solid pharmaceutical compositions containing enalapril maleate
11/30/2005EP1156787B1 Oxadiazole compounds and compositions for delivering active agents
11/30/2005EP1140010B1 Composition and method of sequestration of skin irritants.
11/30/2005EP1121936B1 Preventives and/or remedies for obesity
11/30/2005EP1109909B1 Grf analogs with increased biological potency
11/30/2005EP1056771B1 Streptogramin derivatives, preparation method and compositions containing same
11/30/2005EP0891377B1 Inhibitor and stimulator of haematopoietic stem cell proliferation and uses thereof
11/30/2005EP0870828B1 Novel polypeptide originating from hemophilus paragallinarum and process for producing the same
11/30/2005EP0808364B1 Human pancreatic cell lines: developments and uses
11/30/2005EP0797666B1 Genetically engineered human-derived kunitz domains that inhibit human neutrophil elastase
11/30/2005EP0786005B9 Compositions for treatment of coronary artery diseases using gene therapy.
11/30/2005CN1703524A Genes and polypeptides relating to human pancreatic cancer
11/30/2005CN1703425A Crystallization of IGF-1
11/30/2005CN1703424A GLP-1 derivatives and transmicosal absorption preparations thereof
11/30/2005CN1703248A Drug for auditory dysfunction
11/30/2005CN1703247A Anti-neovasculature preparations for cancer
11/30/2005CN1703238A Recombinant intracellular pathogen immunogenic compositions and methods for use
11/30/2005CN1703237A Treatment of allergic conditions by use of il 21
11/30/2005CN1703235A Method for treating patients with massive blood loss
11/30/2005CN1703234A The use of low-molecular-weight thrombin inhibitor
11/30/2005CN1703227A Methods and compositions for treatment of neurological disorder
11/30/2005CN1703197A Injectable depot compositions and uses thereof
11/30/2005CN1701816A Anti-tumor agent using interleukin-23 gene
11/30/2005CN1701814A F1K-1 is a receptor for vascular endothelial growth factor
11/30/2005CN1229646C Catalytic anti-factor VIII allo-antibodies
11/30/2005CN1229501C Mixture of recombinant vaccinia vectors as poly-envelope protein vaccines for HIV
11/30/2005CN1229499C Phosphodiesterase 8A
11/30/2005CN1229498C Recombinant ribonuclease proteins
11/30/2005CN1229391C Antibody of human gastrointestinal epithelial tumor antigen related to alpha 6 beta 4 integrin
11/30/2005CN1229390C Peptides that lower blood glucose levels
11/30/2005CN1229388C N-terminal modified protein compositions and methods therefor
11/30/2005CN1229385C Composition for stimulating megacaryocyte growth and differentiation and process thereof
11/30/2005CN1229370C Novel derivatives of flavones, xanthones and coumarins
11/30/2005CN1229339C Compounds inhibiting angiogenesis and tumor growth, pharmaceutical preparation containing same and pharmaceutical use thereof
11/30/2005CN1229141C Combination therapy of angiotension converting enzyme inhibitor and epoxy-steroidal aldosterone anatagonist for treatment of cardiovascular disease
11/30/2005CN1229138C Method for accelerating rate of mucociliary clearance
11/30/2005CN1229137C New therapeutic uses of SMR1 peptides
11/30/2005CN1229136C Laerimal gland specific emulsions for topical application to ocular tissue
11/30/2005CN1229113C A Pharmaceutical composition for the treatment of autoimmune diseases
11/30/2005CN1229110C Ophthalmic compositions containing galactomannan polymers and borate
11/30/2005CN1229031C Improved bioactive whey protein hydrolysate
11/29/2005US6969760 Jak kinases and regulation of cytokine signal transduction
11/29/2005US6969758 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of tumors
11/29/2005US6969702 in patient exhibiting disorder selected from neurodegenerative disorders, ischemic disorders, neurological traumas, and learning and memory disorders; calcitonin, exendin and their analogs that elevate intracellular cAMP levels in the tissue
11/29/2005US6969610 Genetically engineering cell structure; obtain cells, amplify intracellular concentration of preferential enzymatic polypeptide, monitor structure of cell
11/29/2005US6969601 MASP-2, a complement-fixing enzyme, and uses for it
11/29/2005US6969599 Nucleic acids encoding tumor necrosis factor receptor TR10
11/29/2005US6969590 Use of a polypeptide for treatment of pruritus in animals
11/29/2005US6969588 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
1 ... 1343 1344 1345 1346 1347 1348 1349 1350 1351 1352 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 ... 3163